This page shows the latest Green Valley news and features for those working in and with pharma, biotech and healthcare.
Gained conditional approval in China in November. To the surprise of the global Alzheimer’s research community, China approved Shanghai Green Valley Pharmaceuticals' algae-based Alzheimer’s treatment GV-971 last ... It seems that Green Valley
China’s regulatory agency has granted a conditional approval to an Alzheimer’s drug from Shanghai Green Valley Pharmaceuticals that is due to start phase 3 trials in the US and ... Green Valley says it will launch Oligomannate in China 'very soon'
More from news
Approximately 2 fully matching, plus 0 partially matching documents found.
Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...